Genetic Technologies
GENE
#10465
Rank
โ‚น0.33 B
Marketcap
โ‚น69.65
Share price
0.00%
Change (1 day)
-66.98%
Change (1 year)

EPS for Genetic Technologies (GENE)

EPS in 2018 (TTM): N/A

In 2023 the company made an earnings per share (EPS) of -โ‚น3.03 a decrease over its 2022 EPS that were of -โ‚น2.01.

EPS history for Genetic Technologies from 2001 to 2018

Annual EPS

Year EPS Change
2023-โ‚น3.0350.65%
2022-โ‚น2.01-99.04%
2021-โ‚น208.79-46.67%
2020-โ‚น391.48-99.38%
2019-โ‚น62,63610809.09%
2018-โ‚น574.17-41.07%
2017-โ‚น974.34-18.37%
2016-โ‚น1,194-40.24%
2015-โ‚น1,997-53.41%
2014-โ‚น4,287-10.66%
2013-โ‚น4,79971.3%
2012-โ‚น2,801-622.73%
2011โ‚น535.89-108.8%
2010-โ‚น6,090-3.92%
2009-โ‚น6,33873.47%
2008-โ‚น3,65424.96%
2007-โ‚น2,924-10.93%
2006-โ‚น3,283-48.62%
2005-โ‚น6,389-8.31%
2004-โ‚น6,968
2003N/A-100%
2002-โ‚น4,327-9.36%
2001-โ‚น4,773

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
โ‚น1,618N/A๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
โ‚น786.60N/A๐Ÿ‡บ๐Ÿ‡ธ USA
Danaher
DHR
โ‚น461.58N/A๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
โ‚น933.17N/A๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
-โ‚น27.31N/A๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Neogen
NEOG
-โ‚น252.24N/A๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
-โ‚น394.21N/A๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-โ‚น6,984N/A๐Ÿ‡บ๐Ÿ‡ธ USA